Keywords
conformational analysis
cyclo-L-prolylglycine
molecular electrostatic potential
nootropic drugs
piracetam
Abstract
The molecular electrostatic potential of the classical nootropic drug piracetam in several of its probable conformations was shown to resemble that of the neuropeptide cyclo-L-prolylglycine in its rigidly fixed conformation. Furthermore, the probability of observing this specific conformation was found to be close to the activity ratio of piracetam to cyclo-L-prolylglycine. These results support the previously proposed hypothesis that cyclo-L-prolylglycine is an endogenous analog of piracetam.
Funders
Ministry of Education and Science of the Russian Federation
121021000105-7
References
1.
Gudasheva T.A., Boyko S.S., Akparov V.K., Ostrovskaya R.U., Skoldinov S.P., Rozantsev G.G., Voronina T.A., Zherdev V.P., Seredenin S.B.
FEBS Letters,
1996
2.
Fan D., Krishnamurthi R., Harris P., Barber P.A., Guan J.
Annals of Clinical and Translational Neurology,
2019
3.
ref-10.71267-mendc7453-1-5-1-0
R. U. Ostrovskaya, T. A. Gudasheva, T. A. Voronina and S. B. Seredenin
Eksp. Klin. Farmakol.,
2002
4.
Gudasheva T.A., Ostrovskaya R.U., Trofimov S.S., Voronina T.A., Skoldinov A.P., Seredenin S.B.
Bulletin of Experimental Biology and Medicine,
1999
5.
ref-10.71267-mendc7453-1-8-1-0
K. N. Kolyasnikova, T. A. Gudasheva, G. A. Nazarova, P. I. Antipov, S. V. Nikolaev, T. A. Antipova, T. A. Voronina and S. B. Seredenin
Eksp. Klin. Farmakol.,
2012
6.
Ahmed A.H., Oswald R.E.
Journal of Medicinal Chemistry,
2010
7.
Bayly C.I., Cieplak P., Cornell W., Kollman P.A.
The Journal of Physical Chemistry,
1993
8.
Shulga D.A., Oliferenko A.A., Pisarev S.A., Palyulin V.A., Zefirov N.S.
SAR and QSAR in Environmental Research,
2008
9.
Frolov V.S., Shulga D.A., Shaimardanov A.R., Palyulin V.A.
Russian Chemical Bulletin,
2025